Distinct presentation of Moyamoya disease in Iran

Masoud Mehrpour1, Mehrdad Farahani2, Sajjad Effatnejad3

  • 1Department of Neurology, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran.

Insights

This study reveals unique features of Moyamoya disease in Iranians, noting a female majority and frequent bilateral artery blockages. Further research is needed on interventions for this rare cerebrovascular disorder.

Area of Science:

  • Neurology
  • Vascular Medicine
  • Epidemiology

Background:

  • Moyamoya disease (MMD) is a rare cerebrovascular disorder.
  • Stenosis of internal carotid arteries characterizes MMD.
  • Limited data exists on MMD characteristics in Iranian populations.

Purpose of the Study:

  • To investigate the clinical characteristics of Moyamoya disease in Iranian patients.
  • To describe demographic, clinical, and treatment patterns of MMD in Iran.

Main Methods:

  • Prospective case series of 15 MMD patients diagnosed between 2010-2020.
  • Data collected on demographics, presentation, comorbidities, vascular lesions, treatments, and outcomes.
  • Follow-up data analyzed for clinical events and mortality.

Main Results:

  • Female predominance (60%) observed.
  • All patients experienced Cerebrovascular Accidents (CVA) at onset.
  • High prevalence of comorbidities: hypertension (33.3%), diabetes (20%), seizures (20%).
  • Bilateral vascular lesions occurred in 53.4% of patients.
  • Direct bypass surgery performed in 40% of cases.
  • Mean follow-up was 16.3 months; 2 deaths and 1 new CVA occurred.

Conclusions:

  • Iranian MMD patients exhibit distinct features: female predominance, frequent ischemic symptoms, and high rates of bilateral occlusions.
  • Further studies are essential to evaluate interventions for symptom prevention in this population.

Related Concept Videos

Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
193
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
299
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
384
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.7K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
471
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
339